13 completed, 1 terminated. 11 Phase 3, 2 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 11 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Mylan Bertek Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group Sulfamylon® For 5 % Topical Solution, Topical Antimicrobial/Antifungal Medications - Burns | Phase 4 | Terminated | Mylan Inc. | 220 | 2007-09-01 | 2022-09-29 |
| Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension Nebivolol (NEB), Metoprolol (MET) - Hypertension | Phase 3 | Completed | Mylan Bertek Pharmaceuticals | 336 | 2005-08-01 | 2022-03-15 |
| Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans Nebivolol and Atenolol - Hypertension | Phase 3 | Completed | Mylan Bertek Pharmaceuticals | 630 | 2005-04-01 | 2008-03-07 |
| A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo Nebivolol, Atenolol, Moxifloxacin - Hypertension | Phase 1 | Completed | Mylan Bertek Pharmaceuticals | 260 | 2003-06-01 | 2005-09-12 |
| A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension Nebivolol - Hypertension | Phase 3 | Completed | Mylan Bertek Pharmaceuticals | 600 | 2002-10-01 | 2005-09-20 |
| A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate Hypertension Nebivolol and Atenolol - Hypertension | Phase 2 | Completed | Mylan Bertek Pharmaceuticals | 110 | 2002-05-01 | 2005-12-16 |
| A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive Patients Nebivolol - Hypertension | Phase 3 | Completed | Mylan Bertek Pharmaceuticals | 845 | 2002-03-01 | 2005-12-16 |
| Dosing Study of the Effects of Nebivolol on Blood Pressure in Black Patients With Mild to Moderate Hypertension Nebivolol - Hypertension | Phase 3 | Completed | Mylan Bertek Pharmaceuticals | 300 | 2001-11-01 | 2005-09-14 |
| A Study Evaluating the Effects of Nebivolol on Blood Pressure in Hypertensive Patients Nebivolol - Hypertension | Phase 3 | Completed | Mylan Bertek Pharmaceuticals | 825 | 2001-09-01 | 2005-09-20 |
| A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients Nebivolol - Hypertension | Phase 3 | Completed | Mylan Bertek Pharmaceuticals | 800 | 2001-09-01 | 2005-09-20 |
| Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease apomorphine HCl injection - Parkinson Disease | Phase 3 | Completed | Mylan Bertek Pharmaceuticals | 60 | 2001-07-01 | 2005-12-16 |
| A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients. apomorphine HCl injection - Parkinson Disease | Phase 3 | Completed | Mylan Bertek Pharmaceuticals | 56 | 2001-02-01 | 2005-09-05 |
| Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months apomorphine HCl injection - Parkinson Disease | Phase 2 / Phase 3 | Completed | Mylan Bertek Pharmaceuticals | 16 | 1999-09-01 | 2005-12-16 |
| Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease apomorphine HCl injection - Parkinson Disease | Phase 3 | Completed | Mylan Bertek Pharmaceuticals | 800 | 1999-07-01 | 2005-09-02 |
Hypertension (9) · Parkinson Disease (4) · Burns (1) · Motor Activity (1)
Nebivolol (9) · Apomorphine (4) · Atenolol (3) · Amphotericin B (1) · Anti-Infective Agents (1) · Bacitracin (1) · Mafenide (1) · Metoprolol (1) · Moxifloxacin (1) · Solutions (1)
United States (11) · United Kingdom (1)
Betty S. Riggs, MD, MBA (7) · Will Sullivan (4) · Betty S Riggs, MD, MBA (1) · Eric Davis, MD (1) · Lawrence A Galitz, MD (1) · Will A Sullivan, BS (1)